SPX3,744.52-38.76 -1.02%
DIA299.23-3.56 -1.18%
IXIC11,073.31-75.33 -0.68%

-- Valeo Pharma Brief: Record revenues of $6.1 million in Q3-22, a 27% increase over Q2-22

-- Valeo Pharma Brief: Record revenues of $6.1 million in Q3-22, a 27% increase over Q2-22

MT Newswires · 09/13/2022 13:20

Please log in to view news